Biophan Technologies, Inc. Europe Reports 2005 Development Milestones

ROCHESTER, N.Y.--(BUSINESS WIRE)--Dec. 28, 2005--Biophan Technologies, Inc. (OTCBB: BIPH; FWB: BTN), a developer of next-generation biomedical technology, announced today that Biophan Europe GmbH has reported a series of important operational achievements for the year ended December 31, 2005. Dr. Michael Friebe, CEO of Biophan Europe, highlighted the Company’s progress in developing proprietary solutions that enable fully compatible Magnetic Resonance Imaging (MRI) of stent based medical devices such as heart valves, coronary and peripheral stents, and vena cava filters, as well as new honors and recognitions that it has received.

MORE ON THIS TOPIC